Emanuel Stutz Selected Research

Sarcoma (Soft Tissue Sarcoma)

10/2021

Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emanuel Stutz Research Topics

Disease

7	Hyperthermia 02/2022 - 01/2019
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2019
3	Neoplasms (Cancer) 08/2021 - 02/2014
2	Angiosarcoma of the breast 11/2021 - 08/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 07/2018 - 11/2017
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020
1	Lung Neoplasms (Lung Cancer) 02/2014

Drug/Important Bio-Agent (IBA)

1	Dihydrotachysterol (AT 10)IBA 10/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	saracatinibIBA 02/2014
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 02/2014
1	CrizotinibIBA 02/2014

Therapy/Procedure

9	Radiotherapy 02/2022 - 01/2017
2	Chemoradiotherapy 01/2019 - 01/2017
1	Therapeutics 01/2022
1	Transurethral Resection of Bladder 01/2022
1	Combined Modality Therapy 11/2021
1	Neoadjuvant Therapy 10/2021
1	Re-Irradiation 08/2021
1	Drug Therapy (Chemotherapy) 01/2019
1	Induced Hyperthermia (Thermotherapy) 01/2019